Recent Quotes

My Watchlist

Indicators

MiMedx Group, Inc - Common Stock (NQ: MDXG )

9.100 +0.020 (+0.22%)

Streaming Delayed Price Updated: 4:00 PM EST, Dec 20, 2024 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	1,635,769
Open	8.940
Bid (Size)	8.200 (2)
Ask (Size)	9.550 (3)
Prev. Close	9.080
Today's Range	8.930 - 9.220
52wk Range	5.470 - 10.14
Shares Outstanding	111,946,829
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

12 Health Care Stocks Moving In Thursday's Intraday Session

October 31, 2024

Via Benzinga

Cassava Sciences Announces Changes in Executive Leadership, Enhanced Corporate Governance and Other Initiatives

July 17, 2024

From Cassava Sciences, Inc.

Via GlobeNewswire

Performance

YTD	+15.63%	+15.63%
1 Month	-1.30%	-1.30%
3 Month	+48.45%	+48.45%
6 Month	+33.82%	+33.82%
1 Year	+2.25%	+2.25%

More News

Analyst Bullish On MiMedx's Rapid Growth In $4B Woundcare Market With Innovative Skin Substitutes

July 02, 2024

Via Benzinga

7 Undervalued Biotech Stocks to Buy for Big-Time Returns

July 01, 2024

Via InvestorPlace

Mizuho Maintains Buy Rating for MiMedx Group: Here's What You Need To Know

March 01, 2024

Via Benzinga

Recap: MiMedx Group Q4 Earnings

February 28, 2024

Via Benzinga

MiMedx Group's Earnings: A Preview

October 27, 2023

Via Benzinga

MDXG Stock Earnings: MiMedx Group Beats EPS, Beats Revenue for Q1 2024

April 30, 2024

Via InvestorPlace

12 Health Care Stocks Moving In Wednesday's After-Market Session

February 28, 2024

Via Benzinga

Get Rich Quick With These 3 Biotech Stocks to Buy Now

February 13, 2024

Via InvestorPlace

ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages MiMedx Group, Inc. Investors to Inquire About Securities Class Action Investigation - MDXG

January 22, 2024

Via NewMediaWire

MDXG LOSS ALERT: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages MiMedx Group, Inc. Investors with Losses in Excess of $100K to Inquire About Securities Class Action Investigation – MDXG

January 17, 2024

From Rosen Law Firm

Via Business Wire

MIMEDX ALERT: Bragar Eagel & Squire, P.C. is Investigating MiMedx Group, Inc. on Behalf of MiMedx Stockholders and Encourages Investors to Contact the Firm

January 15, 2024

From Bragar Eagel & Squire

Via GlobeNewswire

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of MiMedx Group, Inc. (MDXG) on Behalf of Investors

January 12, 2024

From Glancy Prongay & Murray LLP

Via Business Wire

INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of MiMedx Group, Inc. (MDXG) on Behalf of Investors

January 12, 2024

From Law Offices of Howard G. Smith

Via Business Wire

The Law Offices of Frank R. Cruz Announces Investigation of MiMedx Group, Inc. (MDXG) on Behalf of Investors

January 11, 2024

From The Law Offices of Frank R. Cruz

Via Business Wire

Rivian Automotive Reports Weak Delivery Figures, Joins JOYY, MiMedx Group And Other Big Stocks Moving Lower On Tuesday

January 02, 2024

Via Benzinga

Chipotle, Amazon, Deckers Outdoor, Capital One And Other Stocks Move Higher On Friday

October 27, 2023

Via Benzinga

Earnings Scheduled For October 30, 2023

October 30, 2023

Via Benzinga

MediWound Announces Collaboration with MIMEDX on EscharEx® Phase III Study

August 15, 2023

From MediWound Ltd.

Via GlobeNewswire

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

August 02, 2023

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session

August 01, 2023

Via Benzinga

MiMedx Targets Profitability with Strategic Realignment, Suspends Knee Osteoarthritis Program Activities

June 21, 2023

Via Benzinga

MiMedx Group (NASDAQ: MDXG) Reports Q1 2023 Financial Results Showing 21.7% Sales Growth

May 03, 2023

Via Spotlight Growth

Veritone, Samsara, Lexicon Pharmaceuticals And Other Big Stocks Moving Higher On Friday

March 03, 2023

Via Benzinga

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.